- Home
- UMH vs KZR Comparison
UMH vs KZR Comparison
Compare UMH & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UMH
- KZR
- Stock Information
- Founded
- UMH 1968
- KZR 2015
- Country
- UMH United States
- KZR United States
- Employees
- UMH N/A
- KZR N/A
- Industry
- UMH Real Estate Investment Trusts
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- UMH Real Estate
- KZR Health Care
- Exchange
- UMH Nasdaq
- KZR Nasdaq
- Market Cap
- UMH 1.3B
- KZR 29.7M
- IPO Year
- UMH N/A
- KZR 2018
- Fundamental
- Price
- UMH $15.18
- KZR $3.95
- Analyst Decision
- UMH Buy
- KZR Hold
- Analyst Count
- UMH 2
- KZR 2
- Target Price
- UMH $20.25
- KZR $9.00
- AVG Volume (30 Days)
- UMH 680.9K
- KZR 36.8K
- Earning Date
- UMH 11-05-2025
- KZR 11-11-2025
- Dividend Yield
- UMH 5.90%
- KZR N/A
- EPS Growth
- UMH N/A
- KZR N/A
- EPS
- UMH 0.13
- KZR N/A
- Revenue
- UMH $250,046,000.00
- KZR N/A
- Revenue This Year
- UMH $6.21
- KZR N/A
- Revenue Next Year
- UMH $5.88
- KZR N/A
- P/E Ratio
- UMH $119.43
- KZR N/A
- Revenue Growth
- UMH 8.49
- KZR N/A
- 52 Week Low
- UMH $14.76
- KZR $3.62
- 52 Week High
- UMH $20.64
- KZR $9.18
- Technical
- Relative Strength Index (RSI)
- UMH 38.00
- KZR 46.17
- Support Level
- UMH $14.76
- KZR $3.76
- Resistance Level
- UMH $15.33
- KZR $4.09
- Average True Range (ATR)
- UMH 0.28
- KZR 0.14
- MACD
- UMH 0.01
- KZR 0.02
- Stochastic Oscillator
- UMH 32.56
- KZR 42.22
About UMH UMH Properties Inc.
UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.